Vvardis Holding Ag Class A (VVVV) closed at $15.00 on November 19, 2026, down 3.0% from the previous close, on volume of 484,080 shares (30-day average 1,217,352).
Data as of November 19, 2026.
vVARDIS Holding AG Closes IPO of 9,722,223 Class A Shares
TipRanks (Mon, 16-Nov 5:44 PM ET)
The NYSE Welcomes vVARDIS as a Publicly Listed Company
PRNewswire (Fri, 13-Nov 5:57 PM ET)
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
PRNewswire (Fri, 13-Nov 8:55 AM ET)
Vvardis Holding AG is a disruptive Swiss healthcare company that engages in research and development as well as business activities to manufacture, sell and distribute dental care products. The company's proprietary peptide-enabled technology platform, Curodont, delivers an early therapeutic solution for tooth decay. Its revenue includes sales of dental care products. Geographically, the maximum revenue of the company is derived from the United States, and the rest from Switzerland, Italy and the United Kingdom.
Vvardis Holding Ag Class A trades on the NYSE stock market under the symbol VVVV.
As of November 19, 2026, VVVV stock price declined to $15.00 with 484,080 million shares trading.
VVVV has a market cap of $2.72 billion. This is considered a Mid Cap stock.
The top ETF exchange traded funds that VVVV belongs to (by Net Assets): CTAG.
VVVV support price is $14.65 and resistance is $16.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VVVV shares will trade within this expected range on the day.